Viewing Study NCT00035061


Ignite Creation Date: 2025-12-24 @ 12:18 PM
Ignite Modification Date: 2025-12-26 @ 4:04 PM
Study NCT ID: NCT00035061
Status: COMPLETED
Last Update Posted: 2006-07-19
First Post: 2002-05-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 2 Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the Urothelium
Sponsor: Eli Lilly and Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module